These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19194909)

  • 21. Membrane-based techniques for the separation and purification of proteins: an overview.
    Saxena A; Tripathi BP; Kumar M; Shahi VK
    Adv Colloid Interface Sci; 2009 Jan; 145(1-2):1-22. PubMed ID: 18774120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A methodology for centrifuge selection for the separation of high solids density cell broths by visualisation of performance using windows of operation.
    Salte H; King JM; Baganz F; Hoare M; Titchener-Hooker NJ
    Biotechnol Bioeng; 2006 Dec; 95(6):1218-27. PubMed ID: 16865731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CHROM²--a method to enhance the dynamic binding capacity, yield and productivity of a chromatographic column.
    Puthirasigamany M; van Beijeren P; Kreis P
    J Chromatogr A; 2012 May; 1236():139-47. PubMed ID: 22436666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Micro biochemical engineering to accelerate the design of industrial-scale downstream processes for biopharmaceutical proteins.
    Titchener-Hooker NJ; Dunnill P; Hoare M
    Biotechnol Bioeng; 2008 Jun; 100(3):473-87. PubMed ID: 18438873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using chromatography in downstream processing.
    Becker C
    Aust J Biotechnol; 1989 Jan; 3(1):18-9. PubMed ID: 2485313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Very large scale monoclonal antibody purification: the case for conventional unit operations.
    Kelley B
    Biotechnol Prog; 2007; 23(5):995-1008. PubMed ID: 17887772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A computer-aided approach to compare the production economics of fed-batch and perfusion culture under uncertainty.
    Lim AC; Washbrook J; Titchener-Hooker NJ; Farid SS
    Biotechnol Bioeng; 2006 Mar; 93(4):687-97. PubMed ID: 16259001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic oligonucleotides: the state-of-the-art in purification technologies.
    Sanghvi YS; Schulte M
    Curr Opin Drug Discov Devel; 2004 Nov; 7(6):765-76. PubMed ID: 15595437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mining manufacturing data for discovery of high productivity process characteristics.
    Charaniya S; Le H; Rangwala H; Mills K; Johnson K; Karypis G; Hu WS
    J Biotechnol; 2010 Jun; 147(3-4):186-97. PubMed ID: 20416347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medium term planning of biopharmaceutical manufacture with uncertain fermentation titers.
    Lakhdar K; Farid SS; Titchener-Hooker NJ; Papageorgiou LG
    Biotechnol Prog; 2006; 22(6):1630-6. PubMed ID: 17137311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration of stochastic simulation with multivariate analysis: short-term facility fit prediction.
    Stonier A; Pain D; Westlake A; Hutchinson N; Thornhill NF; Farid SS
    Biotechnol Prog; 2013; 29(2):368-77. PubMed ID: 23281334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decision-support tool for assessing biomanufacturing strategies under uncertainty: stainless steel versus disposable equipment for clinical trial material preparation.
    Farid SS; Washbrook J; Titchener-Hooker NJ
    Biotechnol Prog; 2005; 21(2):486-97. PubMed ID: 15801789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulfated membrane adsorbers for economic pseudo-affinity capture of influenza virus particles.
    Opitz L; Lehmann S; Reichl U; Wolff MW
    Biotechnol Bioeng; 2009 Aug; 103(6):1144-54. PubMed ID: 19449393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aqueous two-phase extraction as a platform in the biomanufacturing industry: economical and environmental sustainability.
    Rosa PA; Azevedo AM; Sommerfeld S; Bäcker W; Aires-Barros MR
    Biotechnol Adv; 2011; 29(6):559-67. PubMed ID: 21501680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microarray-based gene expression analysis as a process characterization tool to establish comparability of complex biological products: scale-up of a whole-cell immunotherapy product.
    Wang M; Senger RS; Paredes C; Banik GG; Lin A; Papoutsakis ET
    Biotechnol Bioeng; 2009 Nov; 104(4):796-808. PubMed ID: 19591186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Forecasting for fermentation operational decision making.
    Montague GA; Martin EB; O'Malley CJ
    Biotechnol Prog; 2008; 24(5):1033-41. PubMed ID: 19194911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The locks and keys to industrial biotechnology.
    Wohlgemuth R
    N Biotechnol; 2009 Apr; 25(4):204-13. PubMed ID: 19429540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemometrics applications in biotech processes: assessing process comparability.
    Bhushan N; Hadpe S; Rathore AS
    Biotechnol Prog; 2012; 28(1):121-8. PubMed ID: 22302412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated operation of continuous chromatography and biotransformations for the generic high yield production of fine chemicals.
    Bechtold M; Makart S; Heinemann M; Panke S
    J Biotechnol; 2006 Jun; 124(1):146-62. PubMed ID: 16516996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decisional tool to assess current and future process robustness in an antibody purification facility.
    Stonier A; Simaria AS; Smith M; Farid SS
    Biotechnol Prog; 2012 Jul; 28(4):1019-28. PubMed ID: 22641562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.